71 related articles for article (PubMed ID: 9559147)
1. [Morphologic evaluation of occlusion of arteries by hydrogel with enhanced hemostatic effect].
Skuba ND; Goriukhina NA; Adamian AA; Panova NV; Voronkova OS; Titova MI; Trosteniuk NV
Biull Eksp Biol Med; 1998 Feb; 125(2):237-40. PubMed ID: 9559147
[No Abstract] [Full Text] [Related]
2. Biologically active thrombin-containing hydrogels based on poly(2-hydroxyethyl methacrylate) for endovascular occlusion.
Horák D; Svec F; Kálal J; Adamyan A; Titova M; Trostenyuk N; Skuba N; Dan V; Voronkova O; Gumargalieva K
Polim Med; 1991; 21(1-2):31-41. PubMed ID: 1815233
[No Abstract] [Full Text] [Related]
3. Haemostatic activity of ethamsylate and aminocaproic acid adsorbed poly(2-hydroxyethyl methacrylate) particles.
Horák D; Svec F; Adamyan A; Titova M; Skuba N; Voronkova O; Trostenyuk N; Vishnevskii V; Gumargalieva K
Biomaterials; 1992; 13(8):521-6. PubMed ID: 1633225
[TBL] [Abstract][Full Text] [Related]
4. [Morphological validation of the use of polyhydroxyethyl methacrylate-based x-ray contrast emboli for vascular occlusion].
Skuba ND; Adamian AA; Dan VN; Trosteniuk NV; Lopour P
Biull Eksp Biol Med; 1989 Mar; 107(3):379-82. PubMed ID: 2713484
[TBL] [Abstract][Full Text] [Related]
5. [Preparation and hemostatic evaluation of chitosan composite hemostatic membrane].
Li B; Huang Y; Zhang Y; Sun Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Mar; 24(3):340-3. PubMed ID: 20369538
[TBL] [Abstract][Full Text] [Related]
6. Artificial emboli based on poly(2-hydroxyethyl methacrylate) particles in animal experiments.
Horák D; Jelínek F; Krajícková D
J Biomater Sci Polym Ed; 1999; 10(4):455-67. PubMed ID: 10227467
[TBL] [Abstract][Full Text] [Related]
7. The hemostatic agent ethamsylate promotes platelet/leukocyte aggregate formation in a model of vascular injury.
Hernandez MR; Alvarez-Guerra M; Escolar G; Chiavaroli C; Hannaert P; Garay RP
Fundam Clin Pharmacol; 2004 Aug; 18(4):423-30. PubMed ID: 15312148
[TBL] [Abstract][Full Text] [Related]
8. Hydrogels in endovascular embolization. V. Antitumour agent methotrexate-containing p(HEMA).
Horák D; Svec F; Adamyan A; Titova M; Skuba N; Voronkova O; Trostenyuk N; Vishnevskii V; Gumargalieva K
Biomaterials; 1992; 13(6):361-6. PubMed ID: 1610960
[TBL] [Abstract][Full Text] [Related]
9. [Additional hemostatic and angioprotective treatment of gastrointestinal hemorrhage].
Prcić M; Mulaomerović F; Radnić D; Sehović S; Drino E; Cengić F
Med Arh; 1974; 28(3):341-6. PubMed ID: 4620009
[No Abstract] [Full Text] [Related]
10. Poly(HEMA)--based embolic material in endovascular surgery of liver.
Horák D; Sitnikov A; Guseinov E; Kokov L; Titova M; Adamyan A; Gumargalieva K
Polim Med; 2002; 32(3-4):48-62. PubMed ID: 12677651
[TBL] [Abstract][Full Text] [Related]
11. Endovascular occlusion of branches of hepatic artery with poly(2-hydroxyethyl methacrylate) emboli as a single occlusive measure in hepatology.
Guseinov E; Horák D; Titova M; Adamyan A; Kokov L; Kubishkin V; Vishnevskii V; Skuba N; Trostenyuk N
Polim Med; 2000; 30(3-4):65-81. PubMed ID: 11288601
[No Abstract] [Full Text] [Related]
12. Poly(2-hydroxyethyl methacrylate) emboli with increased haemostatic effect for correction of haemorrhage of complex origin in endovascular surgery of children.
Horák D; Galibin IE; Adamyan AA; Sitnikov AV; Dan VN; Titova MI; Shafranov VV; Isakov YF; Gumargalieva KZ; Vinokurova TI
J Mater Sci Mater Med; 2008 Mar; 19(3):1265-74. PubMed ID: 17705055
[TBL] [Abstract][Full Text] [Related]
13. [Electrothrombosis as a treatment measure].
Sedlarik K
Z Exp Chir; 1981; 14(2):107-15. PubMed ID: 7257464
[TBL] [Abstract][Full Text] [Related]
14. [Collagen sponge and its hemostatic properties].
Wu J; Ye P; Sun W; Guan J; Duan L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1998 Mar; 15(1):63-5. PubMed ID: 12549357
[TBL] [Abstract][Full Text] [Related]
15. Thrombolytic efficacy of native recombinant staphylokinase on femoral artery thrombus of rabbits.
Li CJ; Huang J; Yang ZJ; Cao KJ
Acta Pharmacol Sin; 2007 Jan; 28(1):58-65. PubMed ID: 17184583
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy and mechanism of action of ethamsylate, a long-standing hemostatic agent.
Garay RP; Chiavaroli C; Hannaert P
Am J Ther; 2006; 13(3):236-47. PubMed ID: 16772766
[TBL] [Abstract][Full Text] [Related]
17. Combined stent implantation and embolization with liquid 2-polyhydroxyethyl methacrylate for treatment of experimental canine wide-necked aneurysms.
Klisch J; Schellhammer F; Zitt J; Scheufler KM; Pagenstecher A; Nagursky H; Schumacher M
Neuroradiology; 2002 Jun; 44(6):503-12. PubMed ID: 12070725
[TBL] [Abstract][Full Text] [Related]
18. Hydrogels in endovascular embolization. II. Clinical use of spherical particles.
Horák D; Svec F; Kálal J; Adamyan AA; Volynskii YD; Voronkova OS; Kokov LS; Gumargalieva KZ
Biomaterials; 1986 Nov; 7(6):467-70. PubMed ID: 3790678
[TBL] [Abstract][Full Text] [Related]
19. [The preliminary analysis of domestic hydrogel microspheres for endovascular embolization].
Li T; Wang Q; Ling F; Lu Z; Duan C; Wang X
Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):398-400. PubMed ID: 11825422
[TBL] [Abstract][Full Text] [Related]
20. Effects of etamsylate on equine platelets: in vitro and in vivo studies.
Segura D; Monreal L; Pérez-Pujol S; Alonso A; Díaz-Ricart M; Brugués R; Ordinas A; Escolar G
Vet J; 2007 Sep; 174(2):325-9. PubMed ID: 16904352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
